These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33708074)

  • 21. Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.
    Alrehaili AA; Lee JY; Bakhuraysah MM; Kim MJ; Aui PM; Magee KA; Petratos S
    Neural Regen Res; 2018 May; 13(5):896-907. PubMed ID: 29863021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The adenosine A
    Chen Y; Zhang ZX; Zheng LP; Wang L; Liu YF; Yin WY; Chen YY; Wang XS; Hou ST; Chen JF; Zheng RY
    Neurochem Int; 2019 Oct; 129():104490. PubMed ID: 31226280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis.
    Ponomarev ED; Shriver LP; Maresz K; Pedras-Vasconcelos J; Verthelyi D; Dittel BN
    J Immunol; 2007 Jan; 178(1):39-48. PubMed ID: 17182538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring.
    Zager A; Peron JP; Mennecier G; Rodrigues SC; Aloia TP; Palermo-Neto J
    Brain Behav Immun; 2015 Jan; 43():159-71. PubMed ID: 25108214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.
    Neil S; Huh J; Baronas V; Li X; McFarland HF; Cherukuri M; Mitchell JB; Quandt JA
    Brain Behav Immun; 2017 May; 62():332-343. PubMed ID: 28238951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olive Leaf Polyphenols Attenuate the Clinical Course of Experimental Autoimmune Encephalomyelitis and Provide Neuroprotection by Reducing Oxidative Stress, Regulating Microglia and SIRT1, and Preserving Myelin Integrity.
    Giacometti J; Grubić-Kezele T
    Oxid Med Cell Longev; 2020; 2020():6125638. PubMed ID: 32802267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
    Luz A; Fainstein N; Einstein O; Ben-Hur T
    Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
    Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
    J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
    Gao H; Danzi MC; Choi CS; Taherian M; Dalby-Hansen C; Ellman DG; Madsen PM; Bixby JL; Lemmon VP; Lambertsen KL; Brambilla R
    Cell Rep; 2017 Jan; 18(1):198-212. PubMed ID: 28052249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
    Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.